A 1 : 2 copper(II)-tripeptide complex for DNA binding and cleavage agent under physiological conditions

Area of Science:

• Coordination Chemistry
• Biophysical Chemistry
• Medicinal Chemistry

Background:

• Copper-tripeptide complexes are explored for their biological activities.
• Understanding DNA interaction is crucial for developing novel therapeutic agents.

Purpose of the Study:

• To synthesize and characterize a novel copper-tripeptide complex.
• To investigate the DNA-binding and DNA-cleavage capabilities of the complex.

Main Methods:

• Synthesis and structural characterization of the copper-tripeptide complex.
• Spectroscopic analysis (UV-Vis) to determine geometry.
• DNA-binding studies using calf thymus DNA (CT DNA).
• DNA-cleavage assays with plasmid pUC-19 DNA.

Main Results:

• A 1:2 copper-tripeptide complex, [Cu(II)(Boc-His-Gly-His-OMe)(2)](2+), was successfully synthesized.
• The complex exhibits a square-planar geometry around Cu(II), indicated by an absorption band at 577 nm.
• The complex binds to CT DNA via intercalation with an intrinsic binding constant (Kb) of 1.2x10^2 M(-1).
• Hydrolytic DNA cleavage of plasmid pUC-19 DNA was observed at micromolar concentrations under physiological conditions.

Conclusions:

• The synthesized copper-tripeptide complex demonstrates significant DNA-binding and cleavage activity.
• The complex's properties suggest potential for rapid diffusion in pharmacological applications.
• This research highlights the potential of copper-tripeptide complexes as DNA-targeting therapeutic agents.